Published in Oncogene on May 07, 2007
WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell (2009) 3.76
Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev (2009) 3.58
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat Commun (2014) 1.95
The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J Clin Invest (2011) 1.59
miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol Cancer Res (2010) 1.54
Obligate progression precedes lung adenocarcinoma dissemination. Cancer Discov (2014) 1.47
Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma. PLoS One (2009) 1.39
Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res (2011) 1.37
CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma. Cancer Res (2012) 1.32
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression. J Clin Invest (2012) 1.29
Multiple stress signals activate mutant p53 in vivo. Cancer Res (2011) 1.27
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. J Clin Invest (2014) 1.22
A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model. Cancer Res (2012) 1.09
Smoking, p53 mutation, and lung cancer. Mol Cancer Res (2014) 1.03
The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers. Oncogene (2015) 1.01
Identification of fat4 and tsc22d1 as novel candidate genes for spontaneous pulmonary adenomas. Cancer Res (2011) 0.98
Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression. Mol Cell Biol (2011) 0.96
Estrogen metabolism within the lung and its modulation by tobacco smoke. Carcinogenesis (2012) 0.88
Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma. Oncogene (2011) 0.88
Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers. BMC Genomics (2014) 0.86
The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL. Sci Rep (2016) 0.85
Quantitative ex-vivo micro-computed tomographic imaging of blood vessels and necrotic regions within tumors. PLoS One (2012) 0.85
Novel insights into the molecular origins and treatment of lung cancer. Cell Cycle (2010) 0.85
Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models. Eur Respir Rev (2013) 0.85
SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans. Oncogene (2016) 0.80
ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma. Oncogene (2013) 0.79
Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis. Proc Natl Acad Sci U S A (2016) 0.78
Tumor-stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models. Clin Exp Metastasis (2011) 0.78
Acquisition order of Ras and p53 gene alterations defines distinct adrenocortical tumor phenotypes. PLoS Genet (2012) 0.77
BMP4 depletion by miR-200 inhibits tumorigenesis and metastasis of lung adenocarcinoma cells. Mol Cancer (2015) 0.77
PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung Cancer. Neoplasia (2016) 0.77
An orthotopic mouse model of small cell lung cancer reflects the clinical course in patients. Clin Exp Metastasis (2016) 0.77
Circulating tumor cells from 4D model have less integrin beta 4 expression. J Surg Res (2014) 0.77
Loss of the novel tumour suppressor and polarity gene Trim62 (Dear1) synergizes with oncogenic Ras in invasive lung cancer. J Pathol (2014) 0.76
Mutant p53 establishes targetable tumor dependency by promoting unscheduled replication. J Clin Invest (2017) 0.75
Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development. Oncoscience (2016) 0.75
DNA mismatch repair deficiency accelerates lung neoplasm development in K-ras(LA1/+) mice: a brief report. Cancer Med (2015) 0.75
Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer. Int J Mol Sci (2017) 0.75
Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis. Oncogene (2016) 0.75
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature (1995) 10.18
Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science (1990) 5.47
Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat Genet (2001) 4.23
Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst (1997) 3.03
Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ (2006) 2.95
p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev (2000) 2.74
PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol (1994) 2.68
Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J (1999) 2.64
Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ (2010) 2.43
Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res (2000) 2.34
Effects of N-(4-hydroxyphenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers. J Natl Cancer Inst (2001) 2.18
Long-term impact of smoking on lung epithelial proliferation in current and former smokers. J Natl Cancer Inst (2001) 2.13
Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc Natl Acad Sci U S A (1998) 2.11
p53 mutation heterogeneity in cancer. Biochem Biophys Res Commun (2005) 2.03
Extrapleural solitary fibrous tumor: a clinicopathologic study of 24 cases. Mod Pathol (1999) 1.99
A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. Mol Cell (2001) 1.88
Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53. Genes Dev (1997) 1.88
Thyroid gland ectopias. Ann Otol Rhinol Laryngol (1996) 1.87
The p53-Mdm2 network in progenitor cell expansion during mouse postnatal development. J Pathol (2007) 1.83
Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. J Natl Cancer Inst (1997) 1.79
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J Natl Cancer Inst (1998) 1.78
Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg (1996) 1.77
NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem (1994) 1.73
High metastatic potential in mice inheriting a targeted p53 missense mutation. Proc Natl Acad Sci U S A (2000) 1.73
Analysis of p53 mutants for transcriptional activity. Mol Cell Biol (1991) 1.73
Tissue-specific expression of the mouse alpha 2(I) collagen promoter. Studies in transgenic mice and in tissue culture cells. J Biol Chem (1992) 1.69
Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem (2000) 1.67
An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2. Oncogene (2001) 1.66
In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol (2000) 1.51
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev (2001) 1.50
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst (1999) 1.47
Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes. J Natl Cancer Inst (1998) 1.46
Venting of carbon dioxide-rich fluid and hydrate formation in mid-okinawa trough backarc basin. Science (1990) 1.45
Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck (1998) 1.44
Isolation and characterization of genomic DNA coding for alpha 2 type I collagen. Nucleic Acids Res (1980) 1.43
mdm2 deletion does not alter growth characteristics of p53-deficient embryo fibroblasts. Oncogene (1996) 1.40
Detection and diagnosis of oral neoplasia with an optical coherence microscope. J Biomed Opt (2004) 1.38
Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene. Proc Natl Acad Sci U S A (1991) 1.37
Noninvasive diagnosis of oral neoplasia based on fluorescence spectroscopy and native tissue autofluorescence. Arch Otolaryngol Head Neck Surg (1998) 1.35
Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res (2000) 1.34
Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. Clin Cancer Res (2000) 1.33
c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells. Oncogene (2006) 1.33
Loss of one but not two mdm2 null alleles alters the tumour spectrum in p53 null mice. J Pathol (1999) 1.32
SV40 T antigen abrogates p53-mediated transcriptional activity. Oncogene (1993) 1.31
Mutation of phosphoserine 389 affects p53 function in vivo. J Biol Chem (1996) 1.31
The loss of mdm2 induces p53-mediated apoptosis. Oncogene (2000) 1.31
p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis. Oncogene (2009) 1.29
Papillary squamous cell carcinomas of the upper aerodigestive tract: a clinicopathologic and molecular study. Head Neck (2000) 1.28
Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice. J Virol (1987) 1.24
Loss of PTEN expression as a prognostic marker for tongue cancer. Arch Otolaryngol Head Neck Surg (2001) 1.23
Crippling p53 activities via knock-in mutations in mouse models. Oncogene (2007) 1.19
IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer. Expert Opin Biol Ther (2001) 1.18
Mucosal melanomas of the head and neck. Ann Otol Rhinol Laryngol (1998) 1.18
Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol (2013) 1.18
The intestinal epithelium compensates for p53-mediated cell death and guarantees organismal survival. Cell Death Differ (2008) 1.17
Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells. Oncogene (2010) 1.17
The cenpB gene is not essential in mice. Chromosoma (1998) 1.17
p53 sends nucleotides to repair DNA. Nature (2000) 1.16
Family planning practice and related factors of married women in Ethiopia. Int Nurs Rev (2010) 1.16
Functional replacement of genes for individual polyketide synthase components in Streptomyces coelicolor A3(2) by heterologous genes from a different polyketide pathway. J Bacteriol (1992) 1.16
Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J Clin Oncol (2000) 1.16
A distinct class of vertebrate collagen genes encodes chicken type IX collagen polypeptides. Proc Natl Acad Sci U S A (1985) 1.15
Self-focused ZnO transducers for ultrasonic biomicroscopy. J Appl Phys (2008) 1.15
TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior. Oncogene (2012) 1.14
Three-vessel view of the fetal upper mediastinum: an easy means of detecting abnormalities of the ventricular outflow tracts and great arteries during obstetric screening. Ultrasound Obstet Gynecol (1997) 1.12
Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis. Br J Cancer (1996) 1.11
Structure of the glycosaminoglycan domain in the type IX collagen-proteoglycan. Proc Natl Acad Sci U S A (1987) 1.11
Immunohistochemical expression of Smads 1-6 in the 15-day gestation mouse embryo: signaling by BMPs and TGF-betas. Dev Dyn (2001) 1.11
Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. Am J Pathol (2001) 1.11
Streptomyces linear plasmids that contain a phage-like, centrally located, replication origin. Mol Microbiol (1996) 1.10
Human-B and T-lymphocyte locomotion in response to casein, C5a, and f-met-leu-phe. Cell Immunol (1980) 1.10
Gefitinib for advanced non-small-cell lung cancer and quality of life: expanding and improving treatment options. Ann Oncol (2009) 1.09
All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity. Mol Cell Biol (1999) 1.08
Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin Cancer Res (2001) 1.08
The tumor suppressor p53 regulates its own transcription. Mol Cell Biol (1993) 1.08
Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation. Oncogene (2000) 1.07
Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma. Oncogene (1997) 1.06
Stress pathway activation induces phosphorylation of retinoid X receptor. J Biol Chem (2000) 1.05
The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells. Br J Cancer (2005) 1.05
Independent pathways of p53 induction by cisplatin and X-rays in a cisplatin-resistant ovarian tumor cell line. Cancer Res (1998) 1.05
Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth. Cancer Res (1999) 1.04
Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg (1999) 1.04
Aminopeptidases A, B, and N and dipeptidase D are the four cysteinylglycinases of Escherichia coli K-12. J Bacteriol (2001) 1.03
Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma. Hum Pathol (1996) 1.03
Construction and characterization of cDNA encoding the alpha 2 chain of chicken type IX collagen. Biochemistry (1985) 1.03
Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients. Aliment Pharmacol Ther (2011) 1.02
Mtbp haploinsufficiency in mice increases tumor metastasis. Oncogene (2007) 1.02
Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res (1996) 1.02
Maternal and neonatal outcomes after uterine rupture in labor. Am J Obstet Gynecol (2001) 1.01
Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy. J Clin Oncol (1996) 1.01
Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells. Oncogene (2000) 1.01
The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival. Ann Oncol (2011) 1.00
Malignant intraventricular schwannoma. Case report. J Neurosurg (1995) 0.99
Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair. Oncogene (2010) 0.99
Sero-epidemiology of hepatitis A virus infection among healthcare workers in Korean hospitals. J Hosp Infect (2009) 0.98
Bcl-2 inhibits p53 nuclear import following DNA damage. Oncogene (1997) 0.97
The mutant p53 mouse as a pre-clinical model. Oncogene (2013) 0.97